These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 32602883)

  • 1. Is a "Cytokine Storm" Relevant to COVID-19?
    Sinha P; Matthay MA; Calfee CS
    JAMA Intern Med; 2020 Sep; 180(9):1152-1154. PubMed ID: 32602883
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytokine storm and the prospects for immunotherapy with COVID-19.
    Calabrese LH
    Cleve Clin J Med; 2020 Jun; 87(7):389-393. PubMed ID: 32393592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune status could determine efficacy of COVID-19 therapies.
    Cully M
    Nat Rev Drug Discov; 2020 Jul; 19(7):431-434. PubMed ID: 32546768
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
    Mahmoudi S; Rezaei M; Mansouri N; Marjani M; Mansouri D
    J Clin Immunol; 2020 Oct; 40(7):974-976. PubMed ID: 32648027
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 and rheumatology: is shielding really necessary?
    Amani L; Warraich R; Patel N; Tahir H
    Br J Hosp Med (Lond); 2020 Jun; 81(6):1-3. PubMed ID: 32589537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing Administration of CAR T-Cell Therapy During the COVID-19 Pandemic.
    Bishop MR
    Clin Adv Hematol Oncol; 2020 Jul; 18(7):400-403. PubMed ID: 32903251
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular immune responses to covid-19.
    Sewell HF; Agius RM; Stewart M; Kendrick D
    BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031
    [No Abstract]   [Full Text] [Related]  

  • 8. Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.
    Huang L; Zhao X; Qi Y; Li H; Ye G; Liu Y; Zhang Y; Gou J
    Cell Mol Immunol; 2020 Oct; 17(10):1092-1094. PubMed ID: 32917983
    [No Abstract]   [Full Text] [Related]  

  • 9. Treating COVID-19 with colchicine in community healthcare setting.
    Della-Torre E; Della-Torre F; Kusanovic M; Scotti R; Ramirez GA; Dagna L; Tresoldi M
    Clin Immunol; 2020 Aug; 217():108490. PubMed ID: 32492478
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombotic events in SARS-CoV-2 patients: an urgent call for ultrasound screening.
    Tavazzi G; Civardi L; Caneva L; Mongodi S; Mojoli F
    Intensive Care Med; 2020 Jun; 46(6):1121-1123. PubMed ID: 32322918
    [No Abstract]   [Full Text] [Related]  

  • 11. The many faces of the anti-COVID immune response.
    Vardhana SA; Wolchok JD
    J Exp Med; 2020 Jun; 217(6):. PubMed ID: 32353870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19.
    Joly BS; Siguret V; Veyradier A
    Intensive Care Med; 2020 Aug; 46(8):1603-1606. PubMed ID: 32415314
    [No Abstract]   [Full Text] [Related]  

  • 13. Applying (or Not?) CAR-T Neurotoxicity Experience to COVID-19 Delirium and Agitation.
    Mack AH; Schofield HL
    Psychosomatics; 2020; 61(6):859-860. PubMed ID: 32739050
    [No Abstract]   [Full Text] [Related]  

  • 14. Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome.
    Chen LYC; Hoiland RL; Stukas S; Wellington CL; Sekhon MS
    Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32883678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A plea for the pathogenic role of immune complexes in severe Covid-19.
    Vuitton DA; Vuitton L; Seillès E; Galanaud P
    Clin Immunol; 2020 Aug; 217():108493. PubMed ID: 32526273
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 associated viral myocarditis: does it exist?
    Verma V; Sondhi S; Sharma R; Mahajan K
    Monaldi Arch Chest Dis; 2020 Sep; 90(4):. PubMed ID: 32945641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful use of methylprednisolone for treating severe COVID-19.
    Liu J; Zheng X; Huang Y; Shan H; Huang J
    J Allergy Clin Immunol; 2020 Aug; 146(2):325-327. PubMed ID: 32479759
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment.
    Prete M; Favoino E; Catacchio G; Racanelli V; Perosa F
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
    Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
    Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.